|
US3108117A
(en)
|
1959-02-12 |
1963-10-22 |
Mead Johnson & Co |
3-benzyl-1, 2-diloweralkyl-3-pyrrolidinols
|
|
US3778443A
(en)
|
1969-02-13 |
1973-12-11 |
Ciba Geigy Ag |
4-tetrahydro pyridyl,hydroxy alkyl pyrazoles
|
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
GB1422263A
(en)
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
DE2701705A1
(de)
|
1976-01-28 |
1977-08-04 |
Sandoz Ag |
Neue organische verbindungen, ihre verwendung und herstellung
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
DE3438830A1
(de)
|
1984-10-23 |
1986-04-30 |
Rentschler Arzneimittel |
Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
KR0182801B1
(ko)
*
|
1991-04-16 |
1999-05-01 |
아만 히데아키 |
고체 분산체의 제조방법
|
|
US5817667A
(en)
|
1991-04-17 |
1998-10-06 |
University Of Georgia Research Foudation |
Compounds and methods for the treatment of cancer
|
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
|
JP3265680B2
(ja)
|
1992-03-12 |
2002-03-11 |
大正製薬株式会社 |
経口製剤用組成物
|
|
AU4444393A
(en)
|
1992-09-01 |
1994-03-10 |
Zeneca Limited |
Pyrrolidine derivatives
|
|
GB9310713D0
(en)
|
1993-05-24 |
1993-07-07 |
Zeneca Ltd |
Aryl substituted heterocycles
|
|
ES2229259T3
(es)
|
1995-01-12 |
2005-04-16 |
Glaxo Group Limited |
Derivados de piperidina con actividad antagonista de taquiquinina.
|
|
JP3897360B2
(ja)
|
1995-01-23 |
2007-03-22 |
第一アスビオファーマ株式会社 |
虚血性疾患に基づく症状の改善又は治療薬及びそれに有用な化合物
|
|
DE19504832A1
(de)
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
|
RU2167865C2
(ru)
|
1995-09-07 |
2001-05-27 |
Ф. Хоффманн-Ля Рош Аг |
Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
|
|
EP0858457A1
(de)
|
1995-10-20 |
1998-08-19 |
Dr. Karl Thomae GmbH |
5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung
|
|
EP0867183B1
(en)
|
1996-07-22 |
2004-10-06 |
Daiichi Suntory Pharma Co., Ltd. |
Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
|
|
ATE364374T1
(de)
|
1997-08-11 |
2007-07-15 |
Pfizer Prod Inc |
Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
|
|
US6274735B1
(en)
|
1998-08-10 |
2001-08-14 |
Hoffmann-La Roche Inc. |
Process and intermediates for preparation of substituted piperidines
|
|
IT1303737B1
(it)
|
1998-11-11 |
2001-02-23 |
Smithkline Beecham Spa |
Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
|
|
KR20080104062A
(ko)
|
1998-11-20 |
2008-11-28 |
아레나 파마슈티칼스, 인크. |
사람의 오르판 ｇ 단백질 커플링 수용체
|
|
US20030017528A1
(en)
|
1998-11-20 |
2003-01-23 |
Ruoping Chen |
Human orphan G protein-coupled receptors
|
|
EP1027886B1
(en)
*
|
1999-02-10 |
2008-07-09 |
Pfizer Products Inc. |
Pharmaceutical solid dispersions
|
|
US6221660B1
(en)
|
1999-02-22 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
|
GB9912416D0
(en)
|
1999-05-28 |
1999-07-28 |
Pfizer Ltd |
Compounds useful in therapy
|
|
GB9923177D0
(en)
|
1999-09-30 |
1999-12-01 |
Pfizer Ltd |
Novel polypeptide
|
|
IL139073A0
(en)
|
1999-10-21 |
2001-11-25 |
Pfizer |
Treatment of neuropathy
|
|
EP1176147A1
(en)
|
2000-07-28 |
2002-01-30 |
Pfizer Limited |
Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
|
|
US6770645B2
(en)
|
2001-03-16 |
2004-08-03 |
Pfizer Inc. |
Pharmaceutically active compounds
|
|
US6784185B2
(en)
|
2001-03-16 |
2004-08-31 |
Pfizer Inc. |
Pharmaceutically active compounds
|
|
WO2002088101A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
|
US20030003157A1
(en)
|
2001-06-06 |
2003-01-02 |
University Of Medicine & Dentistry Of New Jersey |
Collagen compositions and methods for making and using the same
|
|
US7262185B2
(en)
|
2001-08-08 |
2007-08-28 |
Takeda Chemical Industries Ltd. |
Benzazepine derivative, process for producing the same, and use
|
|
PL371593A1
(en)
*
|
2002-02-01 |
2005-06-27 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
|
WO2003091216A1
(en)
|
2002-04-25 |
2003-11-06 |
Sumitomo Pharmaceuticals Co., Ltd. |
Novel piperidine derivative
|
|
GB0224919D0
(en)
|
2002-10-25 |
2002-12-04 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
|
GB0230162D0
(en)
|
2002-12-24 |
2003-02-05 |
Metris Therapeutics Ltd |
Compounds useful in inhibiting angiogenesis
|
|
EP1599313B1
(en)
|
2003-03-05 |
2006-07-05 |
Maus S.P.A. |
Method of machining a brake disc
|
|
GB0308333D0
(en)
|
2003-04-10 |
2003-05-14 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1633737A1
(en)
|
2003-06-13 |
2006-03-15 |
Schering Aktiengesellschaft |
Quinolyl amide derivatives as ccr-5 antagonists
|
|
US7132426B2
(en)
|
2003-07-14 |
2006-11-07 |
Arena Pharmaceuticals, Inc. |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
|
MXPA06001202A
(es)
|
2003-07-29 |
2006-08-31 |
Xenon Pharmaceuticals Inc |
Derivados piridilo y su uso como agentes terapeuticos.
|
|
FR2862647B1
(fr)
|
2003-11-25 |
2008-07-04 |
Aventis Pharma Sa |
Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
|
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
|
JP4958560B2
(ja)
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
JP2008501749A
(ja)
|
2004-06-08 |
2008-01-24 |
ニューロサーチ スウェーデン アクチボラゲット |
ドーパミン及びセロトニン神経伝達のモジュレーターとしての新規なジ置換フェニルピペリジン
|
|
WO2006046779A1
(ja)
|
2004-10-29 |
2006-05-04 |
Zeria Pharmaceutical Co., Ltd. |
カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩
|
|
TW200633990A
(en)
|
2004-11-18 |
2006-10-01 |
Takeda Pharmaceuticals Co |
Amide compound
|
|
GB0428526D0
(en)
|
2004-12-30 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
|
AU2005322855B2
(en)
|
2004-12-30 |
2012-09-20 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
US8277495B2
(en)
|
2005-01-13 |
2012-10-02 |
Candela Corporation |
Method and apparatus for treating a diseased nail
|
|
MX2007009949A
(es)
|
2005-02-16 |
2007-09-26 |
Schering Corp |
Pirazinil-piperazin-piperidinas sustituidas con heteroarilo con actividad antagonista de cxcr3.
|
|
BRPI0609928A2
(pt)
|
2005-05-18 |
2010-05-11 |
Wyeth Corp |
inibidores de quinase tpl-2 de 3-cianoquinolina e métodos de fabricação e uso dos mesmos
|
|
EP1888512A2
(en)
|
2005-06-06 |
2008-02-20 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
EP1893593A1
(en)
|
2005-06-15 |
2008-03-05 |
Pfizer Limited |
3-phenylazetidine derivatives as dopamine agonists
|
|
WO2007023507A2
(en)
|
2005-06-20 |
2007-03-01 |
Wockhardt Limited |
Oxazolidinones bearing antimicrobial activity composition and methods of preparation
|
|
WO2007003960A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
|
WO2007003961A2
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
|
BRPI0616245A2
(pt)
|
2005-09-16 |
2011-06-14 |
Arena Pharm Inc |
modulador de metabolismo, seus usos, composiÇço farmaceutica compreendendo o mesmo, bem como mÉtodo para produÇço da referida composiÇço
|
|
JP2009509988A
(ja)
|
2005-09-29 |
2009-03-12 |
サノフィ−アベンティス |
フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
|
|
WO2007066189A2
(en)
*
|
2005-12-09 |
2007-06-14 |
Pfizer Products Inc. |
Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
|
US8343548B2
(en)
*
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
|
US20080103123A1
(en)
|
2006-08-30 |
2008-05-01 |
Biovitrum |
New compounds
|
|
DE602007008470D1
(en)
*
|
2006-10-17 |
2010-09-23 |
Bend Res Inc |
Off
|
|
ATE528300T1
(de)
|
2006-12-06 |
2011-10-15 |
Glaxosmithkline Llc |
Bizyklische verbindungen und ihre verwendung als antidiabetika
|
|
TWI414523B
(zh)
*
|
2006-12-28 |
2013-11-11 |
Metabolex Inc |
用於治療糖尿病及代謝病症之雜環受體促效劑
|
|
US7638541B2
(en)
*
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
|
EP2134704B1
(en)
|
2007-03-08 |
2010-09-22 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
|
EP2014656A3
(en)
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
|
AU2008279447A1
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
|
|
UY31232A1
(es)
|
2007-07-19 |
2009-03-02 |
|
Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
|
|
JP5241834B2
(ja)
|
2007-07-19 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
プロテインキナーゼ阻害剤としての複素環アミド化合物
|
|
FR2918986B1
(fr)
|
2007-07-19 |
2009-09-04 |
Sanofi Aventis Sa |
Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
|
|
EP2220055A2
(en)
|
2007-07-19 |
2010-08-25 |
F. Hoffmann-La Roche AG |
Novel heterocyclyl compounds and their use as chemokine antagonists
|
|
PL2019104T3
(pl)
|
2007-07-19 |
2014-03-31 |
Sanofi Sa |
Środki cytotoksyczne obejmujące nowe pochodne tomaymycyny i ich zastosowanie terapeutyczne
|
|
US20100249163A1
(en)
|
2007-12-04 |
2010-09-30 |
Daniel Dube |
Renin inhibitors
|
|
BRPI0909469A2
(pt)
*
|
2008-03-31 |
2015-12-29 |
Metabolex Inc |
compostos de oximetileno de arila e usos dos mesmos
|
|
MX2010013876A
(es)
|
2008-06-20 |
2011-03-04 |
Metabolex Inc |
Agonistas de arilo grpr119 y sus usos .
|
|
US8536176B2
(en)
|
2008-08-01 |
2013-09-17 |
Nippon Chemiphar Co., Ltd. |
GPR119 agonist
|
|
CA2736421A1
(en)
|
2008-09-10 |
2010-03-18 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
US20110160222A1
(en)
|
2008-11-26 |
2011-06-30 |
Metabolex, Inc. |
Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
|
|
JP5667180B2
(ja)
|
2009-07-01 |
2015-02-12 |
イオン メディックス インコーポレイテッド |
哺乳類の有核細胞に由来するマイクロベシクル及びその用途
|
|
US8410127B2
(en)
|
2009-10-01 |
2013-04-02 |
Metabolex, Inc. |
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
|
|
US20110313160A1
(en)
|
2010-06-04 |
2011-12-22 |
Metabolex, Inc. |
Preparation of 5-ethyl-2--pyrimidine
|
|
CN109674753A
(zh)
|
2010-06-23 |
2019-04-26 |
希玛贝治疗股份有限公司 |
固态分散体
|
|
US20120184572A1
(en)
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|